Quarterly report [Sections 13 or 15(d)]

Revenue - Revenue from contracts with customers (Details)

v3.25.2
Revenue - Revenue from contracts with customers (Details)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
USD ($)
customer
item
Jun. 30, 2024
USD ($)
customer
Jun. 30, 2025
USD ($)
item
customer
Jun. 30, 2024
USD ($)
customer
Dec. 31, 2024
USD ($)
Revenue          
Revenue $ 13,677,000 $ 128,231,000 $ 20,962,000 $ 133,909,000  
Number of contracts with customers | customer 2 3 2 3  
Deferred revenue increase         $ 4,008,000
Deferred revenue $ 112,119,000   $ 112,119,000   $ 108,111,000
Revenue recognized in the period     5,812,000    
Amount of increase in deferred income caused by the change in the exchange rate     $ 9,820,000    
Exchange rate 1.37   1.37   1.25
Aggregate amount of the transaction price that is allocated to performance obligations $ 121,309,000   $ 121,309,000    
Number of Authorized Treatment Centers | item     20    
Product revenue, net          
Revenue          
Revenue $ 11,078,000   $ 15,126,000    
Number of Authorized Treatment Centers | item 5   9    
Development revenue          
Revenue          
Revenue $ 2,599,000 $ 128,231,000 $ 5,836,000 $ 133,909,000